Pharmacokinetics of Ferric Bepectate - A New Intravenous Iron Drug for Treating Iron Deficiency

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.13219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Intravenous Ferric Carboxymaltose for Heart Failure With Iron Deficiency

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Treatment of Iron Deficiency and Iron Deficiency Anemia With Intravenous Ferric Carboxymaltose in Pregnancy

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2018English

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency

Advances in Therapy
MedicinePharmacology
2020English

Pcv39 - Assessment of the Budget Impact of Intravenous Ferric Carboxymaltose (Fcm) for Treating Iron Deficiency Anemia in Congestive Heart Failure Patients in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Comment on the Comparative Safety of Intravenous Ferumoxytol Versus Ferric Carboxymaltose in Iron Deficiency Anemia

American Journal of Hematology
Hematology
2018English

Intravenous Iron Treatment in Pregnancy: Comparison of High-Dose Ferric Carboxymaltose vs. Iron Sucrose

Journal of Perinatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Is an Additional Dose of Intravenous Ferric Carboxymaltose Useful in the Treatment of Iron Deficiency Anemia?

International Journal of Blood Research and Disorders
2019English

A Method to Improve Iron Compliance in Treating Iron Deficiency Anaemia in Pregnancy

Journal of Evolution of Medical and Dental Sciences
2019English

Comparison of Intravenous Iron Sucrose With Oral Iron in Pregnant Women With Iron Deficiency Anaemia

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy